Tuesday, December 30, 2014 10:37:13 PM
I don't know if this is a good move or a bad move.
I just think it's just a move ONVO had to make in the event the cash they have runs out before sales.
ONVO is sensitive to the position they're in right now and the way they've presented themselves to the investing community - I'm thinking they STILL have no real revs at this point. the company has done a lot of pumping, they've whipped up some Media PR, and they have their BB guys pulling out all the stops, pumping hard.
I believe they still need to put contingencies in place if they have no sales by end of CY 1Q.
I'll be watching tomorrows opening. I don't think real investors will just sit in place with the BB pumpers suggesting (tonight on the "other board" ) there's no real impact with this financing solution. Laughable. Fact is, if you're preparing an equity line you're going to draw, sooner than later.
I suspect experienced investors will see through this hocus-pocus and sell off immediately (after hours trading already has this down 16 cents).
I definitely don't think this will be a one-day-down event - market open will see selling and shorts will jump the crap out of this...IMO back to the 6's/low 7s.
I just think it's just a move ONVO had to make in the event the cash they have runs out before sales.
ONVO is sensitive to the position they're in right now and the way they've presented themselves to the investing community - I'm thinking they STILL have no real revs at this point. the company has done a lot of pumping, they've whipped up some Media PR, and they have their BB guys pulling out all the stops, pumping hard.
I believe they still need to put contingencies in place if they have no sales by end of CY 1Q.
I'll be watching tomorrows opening. I don't think real investors will just sit in place with the BB pumpers suggesting (tonight on the "other board" ) there's no real impact with this financing solution. Laughable. Fact is, if you're preparing an equity line you're going to draw, sooner than later.
I suspect experienced investors will see through this hocus-pocus and sell off immediately (after hours trading already has this down 16 cents).
I definitely don't think this will be a one-day-down event - market open will see selling and shorts will jump the crap out of this...IMO back to the 6's/low 7s.
Recent VIVS News
- VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing • GlobeNewswire Inc. • 04/28/2026 12:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/06/2026 05:27:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:05:10 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 04/02/2026 08:00:55 PM
- VivoSim Announces Pricing of up to a $4 Million Public Offering • GlobeNewswire Inc. • 04/01/2026 12:05:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/31/2026 02:17:06 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/27/2026 09:26:52 PM
- VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs • GlobeNewswire Inc. • 03/24/2026 12:05:00 PM
- VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales • GlobeNewswire Inc. • 03/03/2026 01:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 09:05:26 PM
- VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego • GlobeNewswire Inc. • 02/11/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 12:59:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 12:51:43 AM
- VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China • GlobeNewswire Inc. • 01/29/2026 09:05:00 PM
- VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer • GlobeNewswire Inc. • 01/06/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 09:05:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2025 11:07:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:08:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2025 09:07:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/03/2025 09:06:32 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/28/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2025 12:45:18 AM
